𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Circulating biomarkers for vascular endothelial growth factor inhibitors in renal cell carcinoma

✍ Scribed by Amado J. Zurita; Eric Jonasch; Hua-Kang Wu; Hai T. Tran; John V. Heymach

Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
201 KB
Volume
115
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Expression of vascular endothelial growt
Expression of vascular endothelial growth factor in renal cell carcinoma is correlated with cancer advancement
✍ Ching-Chiang Yang; Kang-Chu Chu; Wen-Meng Yeh πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 137 KB πŸ‘ 1 views

## Abstract Vascular endothelial growth factor (VEGF) functions as a regulator of neovascularization in malignant cells. VEGF as a mitogen is thought to alter renal cell carcinoma formation and tumor progression. We investigated the expression of the VEGF gene in order to evaluate its clinical sign

Circulating platelet-derived endothelial
Circulating platelet-derived endothelial cell growth factor increases in hepatocellular carcinoma patients
✍ Kenji Jin-no; Masahito Tanimizu; Ichinosuke Hyodo; Yoshiyuki Nishikawa; Yasushi πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 463 KB πŸ‘ 2 views

classified into two groups based on TNM stage: early and advanced stage disease groups. PD-ECGF expressions in HCC tissues were immunohistologically examined.